Human Microphysiological Model of Afferent Nociceptive Signaling
传入伤害性信号传导的人体微生理模型
基本信息
- 批准号:10348860
- 负责人:
- 金额:$ 197.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-26 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcuteAcute pain managementAdverse effectsAnalgesicsBehaviorBiological ModelsCategoriesCellsChronicCustomDrug IndustryElectric StimulationEngineeringEpidemicEvaluationHumanLibrariesMicroelectrodesMicrofluidicsMicrogliaModelingNarcoticsNatureNervous system structureNeurogliaNeuromodulatorNociceptionOpioidOrganoidsPainPain managementPathway interactionsPatientsPharmaceutical PreparationsPhasePhenotypePhysiologicalPlayPosterior Horn CellsPropertyProtocols documentationRapid screeningRoleSensorySignal TransductionSpecificitySpinalSpinal CordSpinal cord posterior hornStructureSystemTechnologyTestingWorkaddictionbasebiofabricationbody systemchronic paindesigndorsal horndrug candidatehuman modelhuman pluripotent stem cellimprovedinnovationmicrophysiology systemneural networkneuroregulationnext generationnovelopiate tolerancepain modelpain reliefpain signalpublic health relevancerelating to nervous systemscreeningthree-dimensional modelingtransmission process
项目摘要
PROJECT SUMMARY
The management of pain—both acute and chronic—can be a frustratingly futile endeavor for both patients
and clinicians. Desperate attempts at treatment with opioids and other narcotics has led to a heartbreaking and
calamitous epidemic of addiction to prescription painkillers. This epidemic has prompted federal agencies and
the pharmaceutical industry to work toward the identification of the next generation of analgesics. Unfortunately,
there are few adequate model systems currently in use to enable rapid screening of the analgesic properties of
drug candidates. There is an acute need for next-generation neural microphysiological systems that are useful
for identifying drug candidates for problems such as pain. Most current microphysiogical models of the nervous
system tend toward two categories: organoids and microfluidic/ microelectrode chips. We postulate that the
unique complexity and structure of the nervous system demand an integrated approach in order to realize
designs of neural microphysiological systems that can begin to account for the basic physiological units that
assemble to produce emergent behaviors of the nervous system.
We propose to develop a human cell-based model of the afferent pain pathway in the dorsal horn of the
spinal cord. Our approach is innovative because it utilizes novel human pluripotent stem cell (hPSC)-derived
phenotypes in a model that combines the 3D nature of organoid culture with the structural and organizational
specificity of microfabricated systems, all on an integrated, custom 3D microelectrode array. The resulting culture
platform will be the only available human model of the dorsal horn afferent circuit. The objectives of the proposal
will be met in two phases. In the first, we will establish the feasibility of a physiologically relevant, human, 3D
model of the afferent pain pathway that will be useful for evaluation of candidate analgesic drugs. In the second
phase, we will then improve the physiological relevance of the system by promoting neural network maturation
before then demonstrating the system’ utility in modeling adverse effects of opioids and screening a library of
compounds to validate the model. Completion of the objective will establish novel protocols for deriving dorsal
horn neurons from hPSCs and create the first human microphysiological model of the spinal cord dorsal horn
afferent sensory pathway.
项目摘要
疼痛的管理-急性和慢性-可以是一个令人沮丧的徒劳的奋进,为双方的病人
和临床医生。绝望地尝试用阿片类药物和其他麻醉剂治疗,导致了令人心碎的,
对处方止痛药上瘾的灾难性流行这种流行病促使联邦机构和
制药业致力于鉴定下一代止痛药。很不幸的是,
目前很少有足够的模型系统用于快速筛选
候选药物迫切需要下一代神经微生理系统,
用于识别治疗疼痛等问题的候选药物。目前大多数神经系统的微生理模型
系统趋向于两类:类器官和微流体/微电极芯片。我们假设,
神经系统独特的复杂性和结构需要一种综合的方法来实现
神经微生理系统的设计,可以开始解释基本的生理单位,
聚集起来产生神经系统的紧急行为。
我们建议建立一个基于人类细胞的模型,在背角的传入疼痛通路,
脊髓我们的方法是创新的,因为它利用了新的人类多能干细胞(hPSC)衍生的
表型的模型,结合了三维性质的类器官文化的结构和组织
微加工系统的特异性,所有这些都在集成的定制3D微电极阵列上。所得培养物
平台将是背角传入回路的唯一可用的人体模型。提案的目标
将分两个阶段进行。首先,我们将建立一个生理相关的,人类的,3D的可行性,
传入疼痛通路的模型,这将是有用的候选镇痛药物的评价。在第二
阶段,我们将通过促进神经网络成熟来改善系统的生理相关性
然后展示该系统在模拟阿片类药物的不良作用和筛选阿片类药物库方面的实用性。
化合物来验证模型。目标的完成将建立新的协议,
角神经元,并创建第一个人类脊髓背角微生理模型
传入感觉通路
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randolph S Ashton其他文献
Randolph S Ashton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randolph S Ashton', 18)}}的其他基金
Evaluating Human Pluripotent Stem Cell-Derived Neural Rosette Arrays as a Neural Tube Defect Risk Screening Platform
评估人类多能干细胞衍生的神经花环阵列作为神经管缺陷风险筛查平台
- 批准号:
10218408 - 财政年份:2021
- 资助金额:
$ 197.89万 - 项目类别:
Evaluating Human Pluripotent Stem Cell-Derived Neural Rosette Arrays as a Neural Tube Defect Risk Screening Platform
评估人类多能干细胞衍生的神经花环阵列作为神经管缺陷风险筛查平台
- 批准号:
10369044 - 财政年份:2021
- 资助金额:
$ 197.89万 - 项目类别:
High-Throughput Modeling of ALS Using iPSC-Derived Neural Tube Microarrays
使用 iPSC 衍生的神经管微阵列对 ALS 进行高通量建模
- 批准号:
8900372 - 财政年份:2014
- 资助金额:
$ 197.89万 - 项目类别:
High-Throughput Modeling of ALS Using iPSC-Derived Neural Tube Microarrays
使用 iPSC 衍生的神经管微阵列对 ALS 进行高通量建模
- 批准号:
8700618 - 财政年份:2014
- 资助金额:
$ 197.89万 - 项目类别:
High-Throughput Modeling of ALS Using iPSC-Derived Neural Tube Microarrays
使用 iPSC 衍生的神经管微阵列对 ALS 进行高通量建模
- 批准号:
9548846 - 财政年份:2014
- 资助金额:
$ 197.89万 - 项目类别:
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 197.89万 - 项目类别:
Transforming Post-Fracture Acute Pain Management in Older Men and Women through Mobile Health Application
通过移动健康应用程序改变老年男性和女性的骨折后急性疼痛管理
- 批准号:
411858 - 财政年份:2019
- 资助金额:
$ 197.89万 - 项目类别:
Miscellaneous Programs
Comparing Acute Pain Management Protocols for Patients with Sickle Cell Disease
镰状细胞病患者急性疼痛管理方案的比较
- 批准号:
8768023 - 财政年份:2014
- 资助金额:
$ 197.89万 - 项目类别:
Efficacy of Acute Pain Management on Chronic Pain Following Lower Extremity Trauma
急性疼痛管理对下肢创伤后慢性疼痛的疗效
- 批准号:
8718488 - 财政年份:2014
- 资助金额:
$ 197.89万 - 项目类别:
Virtual Reality and Acute Pain Management for Children
虚拟现实和儿童急性疼痛管理
- 批准号:
6957892 - 财政年份:2005
- 资助金额:
$ 197.89万 - 项目类别:
Virtual Reality and Acute Pain Management for Children
虚拟现实和儿童急性疼痛管理
- 批准号:
7272767 - 财政年份:2005
- 资助金额:
$ 197.89万 - 项目类别:
Virtual Reality and Acute Pain Management for Children
虚拟现实和儿童急性疼痛管理
- 批准号:
7114475 - 财政年份:2005
- 资助金额:
$ 197.89万 - 项目类别:
A Novel RF TENS Device for Acute Pain Management
用于急性疼痛管理的新型 RF TENS 设备
- 批准号:
6585887 - 财政年份:2002
- 资助金额:
$ 197.89万 - 项目类别:
A SPANISH OUTCOME MEASURE OF ACUTE PAIN MANAGEMENT
西班牙急性疼痛管理的结果衡量标准
- 批准号:
2615658 - 财政年份:1998
- 资助金额:
$ 197.89万 - 项目类别:
ACUTE PAIN MANAGEMENT TO IMPROVE PATIENT OUTCOMES
急性疼痛管理可改善患者预后
- 批准号:
2257918 - 财政年份:1994
- 资助金额:
$ 197.89万 - 项目类别: